Henry Schein Inc (HSIC)
NASDAQ · Healthcare · Medical Distribution
Henry Schein Inc is a Healthcare company with a market capitalization of $9.68B and a trailing P/E ratio of 25.7.
5-Year Price History
Latest Annual Financials · FY ending December 31, 2025
Recent Quarterly Earnings (EPS)
| Quarter | Reported | Actual EPS | Estimate | Surprise |
|---|---|---|---|---|
| Q1 2026 | May 5, 2026 | $1.32 | $1.22 | +8.2% |
| Q4 2025 | February 24, 2026 | $1.34 | $1.30 | +3.1% |
| Q3 2025 | November 4, 2025 | $1.38 | $1.28 | +7.8% |
| Q2 2025 | August 5, 2025 | $0.70 | $0.92 | -23.9% |
| Q1 2025 | May 5, 2025 | $0.88 | $0.90 | -2.2% |
| Q4 2024 | February 25, 2025 | $1.19 | $1.21 | -1.6% |
Other Medical Distribution Stocks
Frequently Asked Questions
What is Henry Schein Inc's market cap?
As of June 29, 2026, Henry Schein Inc (HSIC) has a market capitalization of $9.68B.
What is Henry Schein Inc's P/E ratio?
Henry Schein Inc trades at a trailing price-to-earnings (P/E) ratio of 25.7. Its forward P/E is 15.9.
Does Henry Schein Inc pay a dividend?
Henry Schein Inc does not currently pay a dividend.
What sector is HSIC in?
Henry Schein Inc is in the Healthcare sector, specifically the Medical Distribution industry.
What was Henry Schein Inc's revenue?
In its latest reported fiscal year (ending December 31, 2025), Henry Schein Inc reported revenue of $13.18B and net income of $398.00M.
Ask your own questions about HSIC
Try mrmarket.ai freeData as of June 29, 2026. Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.